| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| tapentadol | 5-hydroxytryptamine receptor 3a | small molecule | NA | drugbank | Acute onset pain[MeSHID:D059787] Neuralgia[MeSHID:D009437] Peripheral Neuropathy[MeSHID:D010523] Patient Discharge[MeSHID:D010351] Chronic pain[MeSHID:D059350] |
NA | approved | unknown |
| tapentadol | delta-type opioid receptor | small molecule | NA | drugbank | Acute onset pain[MeSHID:D059787] Neuralgia[MeSHID:D009437] Peripheral Neuropathy[MeSHID:D010523] Patient Discharge[MeSHID:D010351] Chronic pain[MeSHID:D059350] |
NA | approved | unknown |
| tapentadol | kappa-type opioid receptor | small molecule | NA | drugbank | Acute onset pain[MeSHID:D059787] Neuralgia[MeSHID:D009437] Peripheral Neuropathy[MeSHID:D010523] Patient Discharge[MeSHID:D010351] Chronic pain[MeSHID:D059350] |
NA | approved | unknown |
| tapentadol | mu-type opioid receptor | small molecule | NA | drugbank , DGIDB | Acute onset pain[MeSHID:D059787] Neuralgia[MeSHID:D009437] Peripheral Neuropathy[MeSHID:D010523] Patient Discharge[MeSHID:D010351] Chronic pain[MeSHID:D059350] |
0.41 | approved | agonist |
| tapentadol | sodium-dependent noradrenaline transporter | small molecule | NA | drugbank , DGIDB | Acute onset pain[MeSHID:D059787] Neuralgia[MeSHID:D009437] Peripheral Neuropathy[MeSHID:D010523] Patient Discharge[MeSHID:D010351] Chronic pain[MeSHID:D059350] |
0.78 | approved | inhibitor |
| tapentadol | sodium-dependent serotonin transporter | small molecule | NA | drugbank | Acute onset pain[MeSHID:D059787] Neuralgia[MeSHID:D009437] Peripheral Neuropathy[MeSHID:D010523] Patient Discharge[MeSHID:D010351] Chronic pain[MeSHID:D059350] |
NA | approved | inhibitor |
| click here to return to the previous page | ||||||||